Bristol-Myers Squibb Company (BMY) · page 142 of 197
Uses a specific case study (Bristol-Myers/Celgene) to highlight a contradiction in standard M&A deal dynamics.
Activist deck · expose_contradiction · expose_contradiction · overcrowded density
Slide locked Sign in to view
Slide schematic 7/9
callout 1/2 list 1/1 paragraph 1/1 quote 0/1 source-note 1/1 table 1/1 title 2/2
2 without position callout 1 · quote 1
calloutquote
Components 9
primary callout bullet paragraph quote source-note data action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1